This brochure showcases Clario’s neuroscience imaging expertise and comprehensive support for complex clinical trials. It highlights specialized teams including neuroradiologists, MRI physicists, PET scientists, and imaging technologists who support trials from protocol design through submission. The document outlines capabilities across structural, functional, and molecular imaging, as well as quantitative biomarker analysis. Clario’s experience spans Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, stroke, and rare neurological disorders, with extensive Phase III trial support. Emphasis is placed on data quality, regulatory compliance, site qualification, and centralized image analysis, positioning Clario as a global leader in neuroscience endpoints.

Join for free to read